Department of Radiology, Nippon Medical School Hospital, Tokyo, Japan.
J Ultrasound Med. 2009 Nov;28(11):1429-40. doi: 10.7863/jum.2009.28.11.1429.
The aim of this study was to evaluate the prognostic impact of sonographically determined tumor features in relation to local control of clinical T1 and T2 glottic carcinoma treated by definitive radiation therapy.
Between 1999 and 2005, 72 patients with T1 and T2 glottic carcinoma were evaluated by percutaneous sonography in terms of tumor detectability, maximum tumor dimension, involvement of the anterior commissure, presence of supraglottic, subglottic, or paraglottic spread, and thyroid cartilage invasion. Factor analyses for local control included clinical features, sonographic findings, and treatment factors.
Forty-one lesions (57%) were detected as hypoechoic masses on sonography. For detectable T2 tumors, sonographic and laryngoscopic findings were in agreement in all cases with respect to spread to anatomic subsites. The 3-year local control rate with radiation therapy alone was 82%. Univariate analysis of the sonographic characteristics revealed that the maximum tumor dimension and thyroid cartilage invasion predicted a loss of local control, whereas none of the clinical or treatment characteristics was significant. Multivariate analysis showed that thyroid cartilage invasion was an independent negative prognostic factor for local control.
Sonography provides information about the likely outcome of radiation therapy for patients with clinical T2 glottic carcinoma, although its utility for T1 lesions is not proven. Thyroid cartilage invasion may be an independent negative predictor of the outcome.
本研究旨在评估经皮超声检查所确定的肿瘤特征与 T1 和 T2 声门型喉癌经根治性放疗后的局部控制之间的相关性,并评价其预后价值。
1999 年至 2005 年间,对 72 例 T1 和 T2 声门型喉癌患者进行了经皮超声检查,评估内容包括肿瘤可探测性、最大肿瘤直径、前联合受累情况、是否累及声门上区、声门下区或跨声门区、甲状软骨侵犯情况。局部控制的相关因素分析包括临床特征、超声表现和治疗因素。
41 处病变(57%)在超声上表现为低回声肿块。对于可探测到的 T2 肿瘤,超声和喉镜检查在各解剖亚区的肿瘤扩散情况上完全一致。单纯放疗的 3 年局部控制率为 82%。超声特征的单因素分析显示,最大肿瘤直径和甲状软骨侵犯是局部控制失败的预测因素,而临床或治疗特征均无显著意义。多因素分析显示,甲状软骨侵犯是局部控制的独立负性预后因素。
尽管超声对 T1 病变的应用价值尚未得到证实,但它可为临床 T2 声门型喉癌患者提供放疗后可能的转归信息。甲状软骨侵犯可能是一个独立的负性预测因素。